Alnylam Pharmaceuticals (ALNY) PT Raised to $377 at Wells Fargo
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $283.12 -2.17%
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Rating Summary:
29 Buy, 12 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $377.00 (from $376.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Adobe (ADBE) PT Lowered to $225 at UBS Amid Plans to Pivot to Freemium Model
- Alnylam to Host Tenth “RNAi Roundtable” Webcast Series
- The Lovesac Co. (LOVE) PT Raised to $20 at DA Davidson Following Q1 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
